Press Releases

16 Feb '22
IMAC Holdings, Inc. Announces Completion of Second Cohort of its Phase 1 Clinical Study of Umbilical Cord-Derived Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinson’s Disease
PDF Version
BRENTWOOD, Tenn. , Feb. 16, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC ) (“IMAC” or “the Company”), today announces it has completed the second cohort of its Phase 1 clinical trial for its investigational compound utilizing umbilical cord-derived allogenic mesenchymal stem cells for
09 Feb '22
IMAC Holdings, Inc., Announces Dr. Ben Lerner as Chief Operating Officer
PDF Version
Dr. Lerner, a New York   Times   best - selling author and holistic health and business expert, bring s   healthcare growth experience to IMAC executive team . BRENTWOOD, Tenn. , Feb. 09, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings , Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), a provider of
19 Jan '22
IMAC Holdings, Inc. Enters 2022 with Improved Balance Sheet
PDF Version
Company reduces significant debt in 2021 BRENTWOOD, Tenn. , Jan. 19, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings , Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of
10 Jan '22
IMAC Holdings, Inc. announces expansion of growing clinic in St. Louis area
PDF Version
The Ozzie Smith IMAC Regeneration Center in Webster Groves   relocates to Clock Building ; expansion motivated by growing patient base WEBSTER GROVES, MO , Jan. 10, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings , Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), a provider of innovative medical advancements
Displaying 11 - 16 of 16